Clinical Trial Update: Metformin Experience on Minimal Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating metformin for minimal hepatic encephalopathy in liver cirrhosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Liver Cirrhosis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Liver Cirrhosis, Hepatic Encephalopathy | Phase 4 | Status: UNKNOWN